Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma. - Test2 - elhamkhani - TriplyDB

Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.

Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.

http://www.wikidata.org/entity/Q33916098

about

Adenovirus-mediated delivery of interferon-γ gene inhibits the growth of nasopharyngeal carcinoma Translational regulation of RPA2 via internal ribosomal entry site and by eIF3a N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion.The prognostic value of altered eIF3a and its association with p27 in non-small cell lung cancers.Downregulation of Ras association domain family member 6 (RASSF6) underlies the treatment resistance of highly metastatic nasopharyngeal carcinoma cells.Host age is a systemic regulator of gene expression impacting cancer progression High expression of XPA confers poor prognosis for nasopharyngeal carcinoma patients treated with platinum-based chemoradiotherapy Overexpression of eIF3a in Squamous Cell Carcinoma of the Oral Cavity and Its Putative Relation to Chemotherapy Response.Upregulated Expression of SOX4 Is Associated with Tumor Growth and Metastasis in Nasopharyngeal Carcinoma.Exploring the key genes and signaling transduction pathways related to the survival time of glioblastoma multiforme patients by a novel survival analysis model.Targeting Jab1/CSN5 in nasopharyngeal carcinoma eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation.Suppression of Jab1/CSN5 induces radio- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways Spectrin domain of eukaryotic initiation factor 3a is the docking site for formation of the a:b:i:g subcomplex.Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells.Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells.FASN regulates cellular response to genotoxic treatments by increasing PARP-1 expression and DNA repair activity via NF-κB and SP1 TXNL1-XRCC1 pathway regulates cisplatin-induced cell death and contributes to resistance in human gastric cancer.BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.EIF3i promotes colon oncogenesis by regulating COX-2 protein synthesis and β-catenin activation.Human ABCG2: structure, function, and its role in multidrug resistance.BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer.Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma.Tumor-specific cytolysis caused by an E1B55K-attenuated adenovirus in nasopharyngeal carcinoma is augmented by cisplatin.Regulation of protein translation initiation in response to ionizing radiation.MiR-629 promotes human pancreatic cancer progression by targeting FOXO3.ARHGEF19 interacts with BRAF to activate MAPK signaling during the tumorigenesis of non-small cell lung cancer.Differential response to doxorubicin in breast cancer subtypes simulated by a microfluidic tumor model.eIF3 Regulation of Protein Synthesis, Tumorigenesis, and Therapeutic Response.eIF3: a factor for human health and disease.XPA expression is a predictive marker of the effectiveness of neoadjuvant chemotherapy for locally advanced uterine cervical cancer.Molecular characterization and integrative genomic analysis of a panel of newly established penile cancer cell lines.Elevated serum LAMC2 is associated with lymph node metastasis and predicts poor prognosis in penile squamous cell carcinoma

P2860

Q34526425-10EA3D9D-1B97-448A-8857-A318771EA83A Q34580793-AB849EE7-548D-4168-80DA-DE56D1F0DEBC Q34600331-F7E1C03C-D89E-456D-BC54-524EC18ABA87 Q35161905-98B8082C-6377-4482-A00D-E99835ABD79B Q35207555-BB0182D9-F543-47D8-BFC1-81BF825EDBF2 Q35428467-BA1DD16C-637E-4B36-BEAB-1B521F5EC71E Q35686424-4B85FA1B-7FE8-48E9-9EC3-86B5CB12B1FF Q35944966-E5B68417-7C15-4A94-BE01-04DC923D6934 Q36249545-8293F0BF-9EE3-4FAC-8572-FB1A5307392A Q36280795-8C625160-7E4A-40AB-823B-084AB9B0E9F4 Q36327912-BACCCBB0-ECAF-478C-BA97-5450DFDF5EB6 Q36413207-88813851-E156-4CC9-A235-1C75B10D785A Q36592296-80D5F096-1F0D-499A-8C83-3D5C144DBD15 Q37201229-EEF498A8-CFB7-4B91-A74A-8D4806B1A976 Q37227757-A2C883EF-63BF-43BC-9766-B7C15F2D6281 Q37370299-1802D97B-E7AC-435B-8C4B-0835BF0A14C3 Q37417939-4EFA6B11-2F1A-452E-9A8C-19328E7610A1 Q37620658-0BEB59A3-C968-4BDE-B9A9-EECD107A6A16 Q37648125-9D9EDAE3-837B-4DA8-818B-0D0C646150DB Q37656530-00A0A4FB-2CA2-4DAA-A62D-33D33779CC02 Q38003156-C10DC7AE-017B-41C0-9BAA-277F5DAB20E4 Q38700288-333EB8D3-617D-49CC-A41C-8BF5311BDA22 Q39002027-A391A1B0-9D79-4CE0-8ECB-2145562D3E05 Q42261523-7CDAB8E1-50BB-4F43-8E63-0533D7DE0E73 Q42271914-28D317AA-D8EC-417D-B0EE-39C315951F06 Q46037722-B06EF7D0-FD44-4DA3-BEA9-154FF9D4358A Q47375003-6391E6AA-3BC2-4883-965E-EA47EE0A6E9A Q47645697-A6B7B195-2E58-4817-91E7-A64034BDAC71 Q51334042-FA9B56EE-5C3E-4555-969B-AFDBFD2A00E0 Q52445969-B97D5AA8-63DE-4FD5-8C15-B6B36ABB75B3 Q53700829-6173D070-8587-4DDC-B725-76D65D7967F0 Q55185781-E32CC152-13B9-4DBD-B797-6369A0FF49FD Q58698566-0A2F7D0C-7707-4423-8343-44215CAE6F59

P2860

Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.

http://www.wikidata.org/entity/Q33916098

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Role of eIF3a in regulating ci ...... r of nasopharyngeal carcinoma.

@ast

Role of eIF3a in regulating ci ...... r of nasopharyngeal carcinoma.

@en

type

label

Role of eIF3a in regulating ci ...... r of nasopharyngeal carcinoma.

@ast

Role of eIF3a in regulating ci ...... r of nasopharyngeal carcinoma.

@en

prefLabel

Role of eIF3a in regulating ci ...... r of nasopharyngeal carcinoma.

@ast

Role of eIF3a in regulating ci ...... r of nasopharyngeal carcinoma.

@en

P1433

Q33916098-EA978B2C-81F9-4DBE-BC08-01F16724ECA9

P1476

Q33916098-D546A054-D67E-4FBE-97C9-E1E7D970E531

P2093

Q33916098-1B72CB47-5C88-4CDB-BD31-6BDBC6157DEC

Q33916098-1D8FFE2F-5143-47EC-94BA-3B75CC2DD46A

Q33916098-44348134-1B2D-4CFB-AF75-4C9315B9809F

Q33916098-469E8598-716E-4C59-B61B-B03E399637B5

Q33916098-534F08C1-5791-42DA-A4F0-E1E6AE7657CB

Q33916098-85B99CCB-02B1-49A1-93D9-1B732E082BFA

Q33916098-9B3F5ACD-40EE-42EB-8004-125C73B0A177

Q33916098-9F77B7F6-E443-4143-B6D6-6841AF33B217

Q33916098-D06CDA10-5CB0-4469-A5B7-5E67C3E8641F

Q33916098-D758E6EE-5B7C-411A-BFD4-A5C28CF84AF9

P2860

Q33916098-089F9D89-5C46-43C9-B24D-CFFEA76C2F77

Q33916098-0E25A6D0-7A23-487B-8119-42ED0F30CCB4

Q33916098-22404F49-F6C2-4519-A8C8-587B51BBBE9E

Q33916098-23B6AC4A-BCA8-4BE1-BC46-A9FAC8D95BD8

Q33916098-274F2B69-F16B-4246-A55B-134E9872BD34

Q33916098-279EECD9-F57C-4356-878C-C85ADF94F67F

Q33916098-28689261-3C1C-4705-BA8E-0C7884854A85

Q33916098-290F8DF3-A1D7-406B-A317-F60CCB88CE1A

Q33916098-2E4FEC24-C6FC-4ECC-BAF6-79AEC1F94F73

Q33916098-2FB2F24B-303F-4BFB-B6F7-C9809DEF30DB

P2888

Q33916098-222D9C68-3C68-485B-91F0-453D89A1B164

P304

Q33916098-E0F6C8A8-9DE6-4C1C-9FAF-62882C4F3E69

P31

Q33916098-771D8539-F0B0-4878-A8A3-D995AD8BC170

P356

Q33916098-B70FE5BA-CEAA-4E29-B152-F7B9A6072079

P407

Q33916098-0FC6985B-B15E-4B40-8BF2-D71FBDF10064

P433

Q33916098-CF8A1E6E-BB90-4F00-9971-17A090B54493

P478

Q33916098-C30C01B6-D8D5-49B1-AE92-DE1EE9396DBD

P50

Q33916098-7B366CCD-B727-437C-A8BB-026139A903F9

P577

Q33916098-6F4C56BC-28A6-458F-92DC-6B933F1F698F

P5875

Q33916098-16019A0C-E8FC-404A-8DA2-2F51B689C19C

P6179

Q33916098-D78A8851-8387-40BF-9DB1-685D40B5CDEC

P698

Q33916098-9F7B9D59-AEA3-4F20-9BC8-1165C319DF98

P932

Q33916098-E46EEAE4-8049-424A-B2E0-1C9C9908B7B1

P356

P1433

P1476

Role of eIF3a in regulating ci ...... r of nasopharyngeal carcinoma.

@en

P2093

C-N Qian

http://www.w3.org/2001/XMLSchema#string

D Petillo

http://www.w3.org/2001/XMLSchema#string

J Chen

http://www.w3.org/2001/XMLSchema#string

J Liu

http://www.w3.org/2001/XMLSchema#string

J-T Zhang

http://www.w3.org/2001/XMLSchema#string

J-Y Yin

http://www.w3.org/2001/XMLSchema#string

L Zhou

http://www.w3.org/2001/XMLSchema#string

R-Y Liu

http://www.w3.org/2001/XMLSchema#string

S K Khoo

http://www.w3.org/2001/XMLSchema#string

W Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a 170-kDa protein over-expressed in lung cancers

Regulation of ribonucleotide reductase M2 expression by the upstream AUGs

Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer

Biochemical characterization of mammalian translation initiation factor 3 (eIF3). Molecular cloning reveals that p110 subunit is the mammalian homologue of Saccharomyces cerevisiae protein Prt1

Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints

Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells

Cisplatin: mode of cytotoxic action and molecular basis of resistance

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

Functions of human replication protein A (RPA): from DNA replication to DNA damage and stress responses

Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.

P2888

P304

4814-4823

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2011.189

http://www.w3.org/2001/XMLSchema#string

P407

P433

48

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51177287

http://www.w3.org/2001/XMLSchema#string

P6179

1008461877

http://www.w3.org/2001/XMLSchema#string

P698

21625209

http://www.w3.org/2001/XMLSchema#string

P932

3165083

http://www.w3.org/2001/XMLSchema#string